The estimated Net Worth of Craig Ballaron is at least $155 Тысяча dollars as of 24 August 2020. Mr. Ballaron owns over 10,000 units of Verrica Pharmaceuticals Inc stock worth over $19,300 and over the last 5 years he sold VRCA stock worth over $0. In addition, he makes $135,263 as Independent Director at Verrica Pharmaceuticals Inc.
Craig has made over 1 trades of the Verrica Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of VRCA stock worth $88,800 on 24 August 2020.
The largest trade he's ever made was buying 10,000 units of Verrica Pharmaceuticals Inc stock on 24 August 2020 worth over $88,800. On average, Craig trades about 1,429 units every 0 days since 2019. As of 24 August 2020 he still owns at least 10,000 units of Verrica Pharmaceuticals Inc stock.
You can see the complete history of Mr. Ballaron stock trades at the bottom of the page.
Craig Ballaron serves as Independent Director of the Company. Mr. Ballaron has served as an independent consultant in the pharmaceuticals, cosmeceuticals, physician dispense products and electronics fields since 2016. Mr. Ballaron was the co-founder of Aqua Pharmaceuticals Holdings, Inc. and served as the Chief Executive Officer, President and member of the Board of Directors from 2004 to December 2015. Prior to founding Aqua Pharmaceuticals, Mr. Ballaron held various roles with increasing responsibilities at Bioglan Pharmaceuticals from 1999 to 2004. Mr. Ballaron received his B.S. in Business Management from York College. Our Board of Directors believes that Mr. Ballaron should serve as a director based upon his years of experience as a Chief Executive Officer in the pharmaceutical industry.
As the Independent Director of Verrica Pharmaceuticals Inc, the total compensation of Craig Ballaron at Verrica Pharmaceuticals Inc is $135,263. There are 7 executives at Verrica Pharmaceuticals Inc getting paid more, with Ted White having the highest compensation of $1,441,190.
Craig Ballaron is 59, he's been the Independent Director of Verrica Pharmaceuticals Inc since 2019. There are 1 older and 13 younger executives at Verrica Pharmaceuticals Inc. The oldest executive at Verrica Pharmaceuticals Inc is Lawrence Eichenfield, 62, who is the Director.
Craig's mailing address filed with the SEC is C/O VERRICA PHARMACEUTICALS INC., 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA, 19380.
Over the last 6 years, insiders at Verrica Pharmaceuticals Inc have traded over $8,200,904 worth of Verrica Pharmaceuticals Inc stock and bought 11,305,854 units worth $62,586,502 . The most active insiders traders include Advisors Llcperceptive Life..., Paul B Manning и John A Iii Stalfort. On average, Verrica Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of $213,456. The most recent stock trade was executed by Christopher G. Hayes on 26 August 2024, trading 35,713 units of VRCA stock currently worth $93,211.
verrica pharmaceuticals inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the united states. the company's lead product candidate include vp-102 that is in phase iii clinical trial for the treatment of molluscum contagiosum; in phase ii clinical trial for the treatment of common warts; and completed phase i clinical trial for the treatment of genital warts. it is also developing cantharidin-based product candidate, vp-103 for the treatment of plantar warts. the company has a license agreement with lytix biopharma as to develop and commercialize ltx-315 for dermatologic oncology indications. verrica pharmaceuticals inc. was founded in 2013 and is headquartered in west chester, pennsylvania.
Verrica Pharmaceuticals Inc executives and other stock owners filed with the SEC include: